Pierrel operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pierrel with three other
pharmaceutical manufacturers in Europe:
sales of 134.72 million Norwegian Kroner [US$17.27 million]
of which 46%
was Hexvix/Cysview Own Sales),
(154.80 million Swedish Kronor [US$19.47 million]
of which 100%
was Products & Services), and
based in Russia
(964.22 million Russian Rubles [US$16.59 million]
During the year ended December of 2015, sales at
Pierrel were 15.89 million Euro (US$19.05 million).
decrease of 51.1%
versus 2014, when the company's sales were 32.51 million Euro.